Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P234: Online direct-to-public calprotectin testing in the UK: what is out there in 2023?ECCO'24
Year: 2024
Authors: Bishara, M.(1)*;Smith, R.(1);Nice, R.(2);Roberts, C.(1);Kennedy, N.A.(1);Ahmad, T.(1);Goodhand, J.R.(1);
(1)Royal Devon University Healthcare NHS Foundation Trust, Gastroenterology, Exeter, United Kingdom;(2)Royal Devon University Healthcare NHS Foundation Trust, Blood Sciences Laboratories, Exeter, United Kingdom;
P235: Correlation of mental and psychological status to disease activity in patients with Inflammatory Bowel Disease using The Symptom Checklist -90- Revised Questionnaire (SCL90R).ECCO'24
Year: 2024
Authors: Abdelaty, K.(1)*;
(1)Associate professor, Internal medicine-gastroenterology unit, Alexandria, Egypt;Ezzat Ali Doaa Hedar Nada Osman Moamen Fawzi.
P237: Cognitive debriefing of a patient-reported outcome measure for abdominal pain and loose stool frequency in Crohn’s diseaseECCO'24
Year: 2024
Authors: H. Gibble, T.(1)*;Kosa, K.(2);Basnyat, B.(2);Martin, S.(3);Moses, R.(4);Dubinsky, M.(5);
(1)Eli Lilly & Company, Value- Evidence- and Outcomes, Indianapolis- IL, United States;(2)RTI Health Solutions, Patient-Centered Outcomes Assessment, Research Triangle Park- NC, United States;(3)RTI Health Solutions, Patient-Centered Outcomes Assessment, Ann Arbor- MI, United States;(4)Eli Lilly and Company, Gastroenterology & Immunology, Indianapolis- IL, United States;(5)Icahn School of Medicine at Mount Sinai, Pediatric Gastroenterology, New York- NY, United States;
P238: Autoimmune comorbidities in microscopic colitis: retrospective analysis of consecutive single centre patientsECCO'24
Year: 2024
Authors: Kiudelis, V.(1)*;Kiudeliene, E.(1);Kupcinskas, J.(1);Kupcinskas, L.(1);
(1)Lithuanian University of Health Sciences Hospital Kauno Klinikos, Department of Gastroenterology, Kaunas, Lithuania;
P239: Characteristics and outcomes of portal vein thrombosis in patients with Inflammatory Bowel Disease in KoreaECCO'24
Year: 2024
Authors: Kim, K.J.(1)*;Song, S.(1);Park, J.B.(1);Bae, J.H.(1);Baek, J.E.(1);Kim, G.H.(1);Kim, M.(1);Hong, S.W.(1);Hwang, S.W.(1);Yang, D.H.(1);Ye, B.D.(1);Byeon, J.S.(1);Myung, S.J.(1);Yang, S.K.(1);Yu, C.S.(2);Yoon, Y.S.(2);Lee, J.L.(2);Kim, M.H.(2);Park, S.H.(1);
(1)Asan Medical Center, Gastroenterology, Seoul, Korea- Republic Of;(2)Asan Medical Center, Department of Colon and Rectal Surgery, Seoul, Korea- Republic Of;
P240: The impact of environmental factors in the onset, activity and severity of inflammatory bowel diseases in a population-based Danish setting – findings from IBD Prognosis StudyECCO'24
Year: 2024
Authors: Attauabi, M.(1,2,3)*;Madsen, G.R.(2,3);Bendtsen, F.(2,3);Seidelin, J.(1);Burisch, J.(2,3);
(1)Copenhagen University Hospital - Herlev and Gentofte, Department of Gastroenterology and Hepatology, Herlev, Denmark;(2)Hvidovre Hospital, Copenhagen Center for Inflammatory Bowel Disease in Children- Adolescents- and Adults, Hvidovre, Denmark;(3)Copenhagen University Hospital - Amager and Hvidovre, Gastrounit- Medical Section, Hvidovre, Denmark;
P241: Systemic redox status associates with disease activity and clinical phenotypes in Inflammatory Bowel DiseaseECCO'24
Year: 2024
Authors: Geertsema, S.(1)*;Bourgonje, A.R.(1,2);Gacesa, R.(1);Fagundes, R.R.(1);Spekhorst, L.M.(1);Hu, S.(3);Kannan, A.K.(4);Ruane, D.(4);de Jong, S.(1);Jansen, B.H.(1);Bulthuis, M.L.C.(5);Reinders-Luinge, M.(5);Weersma, R.K.(1);van Goor, H.(5);Dijkstra, G.(1);Faber, K.N.(1);
(1)University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands;(2)Icahn School of Medicine at Mount Sinai, The Henry D. Janowitz Division of Gastroenterology, New York, United States;(3)Institute of Precision Medicine- Sun Yat-Sen University, The First Affiliated Hospital, Guangzhou, China;(4)Janssen LLC, Research & Development, Spring House, United States;(5)University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, The Netherlands;
P242: Immune-cell specific biomarker of early intestinal inflammation: Neutrophil elastase degraded fragment of type III collagen is elevated in patients with Inflammatory Bowel DiseaseECCO'24
Year: 2024
Authors: Tsapanou Katranara, T.(1)*;Pehrsson, M.(1);Alexdottir, M.S.(1);Domislović, V.(2);Krznarić, Ž.(2);Ainsworth, M.A.(3);Boye, T.L.(4);Steenholdt, C.(4);Bay-Jensen, A.C.(1);Karsdal, M.A.(1);Mortensen, J.H.(1);
(1)Nordic Bioscience, Biomarkers and Research, Herlev, Denmark;(2)Clinical Hospital Centre Zagreb, Department of Gastroenterology and Hepatology, Zagreb, Croatia;(3)Odense University Hospital, Department of Medical Gastroenterology, Odense, Denmark;(4)Herlev Hospital, Department of Gastroenterology, Herlev, Denmark;
P243: Multi-modality intestinal ultrasound is accurate and reproducible to distinguish inflammatory from chronic fibrotic strictures in Crohn’s disease – results from the STRICTURE studyECCO'24
Year: 2024
Authors: de Voogd, F.(1)*;Pruijt, M.(1);Beek, K.(2);Van Rijn, K.(2);Van der Bilt, J.(3);Buskens, C.(3);Bemelman, W.(3);Neefjes-Borst, A.(4);Mookhoek, A.(5);Stoker, J.(2);D@E@Haens, G.(6);Gecse, K.(6);
(1)University of Amsterdam- Amsterdam UMC, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(2)University of Amsterdam- Amsterdam UMC, Radiology and Nuclear Medicine, Amsterdam, The Netherlands;(3)University of Amsterdam- Amsterdam UMC, Surgery, Amsterdam, The Netherlands;(4)University of Amsterdam- Amsterdam UMC, Pathology, Amsterdam, The Netherlands;(5)University of Bern, Pathology, Bern, Switzerland;(6)University of Amsterdam- Amsterdam UMC, Gastroenterology and Hepatology, Amsterdam, The Netherlands;
P244: The first step to IBD prevention exploring rate of pre-clinical inflammation in subset of asymptomatic subjects at risk of IBD: screening stage of the PIONIR trialECCO'24
Year: 2024
Authors: Kenigsberg, S.(1);Turpin, W.(2);Lee, S.H.(2);Ledder, O.(1);Shimhlash, Y.(1);Griffiths, A.(3);Huynh, H.Q.(4);El-Matary, W.(5);Otley, A.(6);Avni-Biron, I.(7);Jacobson, K.(8);Panaccione, R.(9);Bitton, A.(10);Croitoru, K.(2);Turner, D.(1)*;
(1)Shaare Zedek Medical Center, Juliet Keidan Institute of Pediatric Gastroenterology Hepatology and Nutrition, Jerusalem, Israel;(2)Mount Sinai Hospital, Joseph and Wolf Lebovic Health Complex- Zane Cohen Centre for Digestive Diseases, Toronto, Canada;(3)The Hospital for Sick Children, Division of Gastroenterology- Hepatology and Nutrition, Toronto, Canada;(4)Stollery Children@E@s Hospital, Pediatric Gastroenterology and Nutrition, Edmonton, Canada;(5)University of Manitoba, Pediatric Gastroenterology, Winnipeg, Canada;(6)Izaak Walton Killam Health Centre, Division of Gastroenterology & Nutrition, Halifax, Canada;(7)Beilinson Hospital, Gastroenterology, Petach Tikva, Israel;(8)BC Children@E@s Hospital, Division of Gastroenterology- Hepatology and Nutrition, Vancouver- BC, Canada;(9)University of Calgary, Inflammatory Bowel Disease Unit, Calgary, Canada;(10)McGill University, Division of Gastroenterology and Hepatology, Montreal, Canada;
P245: Biologics Sequencing in Clinical Units (BISCUITS): Comparing outcomes in Crohn’s disease patients on second-line biologicsECCO'24
Year: 2024
Authors: Bartalucci, G.(1)*;Taylor, F.(2);Gleave, C.(3);Dobson, L.(4);Bodger, K.(5);Dodd, S.(5);Bloom, S.(6);Passey, A.(7);Nissinen, R.(8);Wirth, D.(9);Andreas, D.(10);Lee, J.(11);Cummings, J.R.F.(1);
(1)University Hospital Southampton, Gastroenterology, Southampton, United Kingdom;(2)IBD Registry, Health Informatics, London, United Kingdom;(3)IBD Registry, Project Management, London, United Kingdom;(4)IBD Registry, Senior Management, London, United Kingdom;(5)University of Liverpool, Department of Health Data Science, Liverpool, United Kingdom;(6)IBD Registry, Clinical Lead, London, United Kingdom;(7)Janssen-Cilag, Janssen-Cilag, London, United Kingdom;(8)Janssen-Cilag Oy, Janssen-Cilag Oy, Espoo, Finland;(9)Janssen-Cilag GmbH, Janssen-Cilag GmbH, Neuss, Germany;(10)Janssen-Cilag Farmaceutica LTDA, Janssen-Cilag Farmaceutica LTDA, Sao Paulo, Brazil;(11)Janssen-Cilag A/S, Janssen-Cilag A/S, Birkerod, Denmark;BISCUITS Study Group
P246: Histologic remission is an important therapeutic target in patients who achieve endoscopic remission of ulcerative colitisECCO'24
Year: 2024
Authors: Lee, J.(1)*;Kim, S.J.(1);Lee, D.S.(1);
(1)Chosun University College of Medicine, Gastroenterology, Gwangju, Korea- Republic Of;
P247: Anxiety and depression in newly diagnosed patients with Inflammatory Bowel Disease – Results from the IBSEN III studyECCO'24
Year: 2024
Authors: Johansen, I.(1,2)*;Hagen, M.(3);Løkkeberg, S.T.(1);Kristensen, V.A.(4);Høivik, M.L.(4,5);Lund, C.(4,5);Strande, V.(5,6,7);Glad, I.F.(5,6,7);Bengtson, M.B.(8);Aabrekk, T.B.(8);Cetinkaya, R.(9);Detlie, T.E.(5,10);Frigstad, S.O.(11);Medhus, A.W.(4,5);Holten, K.I.A.(5,12);Hovde, Ø.(5,13);Olsen, B.C.(5,14);Perminov, G.(15);Ricanek, P.(6);Vatn, S.(10,13);Huppertz-Hauss, G.(14);Torp, R.(16);Jelsness-Jørgensen, L.P.(1,12);Opheim, R.(2,4);
(1)Østfold University College, Faculty of Health- Welfare and Org., Fredrikstad, Norway;(2)University of Oslo, Institute of Health and Society, Oslo, Norway;(3)Oslo Metropolitan University, Departement of Public Health, Oslo, Norway;(4)Oslo University Hospital, Department of Gastroenterology, Oslo, Norway;(5)University of Oslo, Institute of Clinical Medicine, Oslo, Norway;(6)Lovisenberg Diaconal Hospital, Department of Gastroenterology, Oslo, Norway;(7)Unger-Vetlesen Institute, Lovisenberg Diaconal Hospital, Oslo, Norway;(8)Vestfold Hospital Trust, Department of Gastroenterology, Tønsberg, Norway;(9)Diakonhjemmet Hospital, Department of Medicine, Oslo, Norway;(10)Akershus University Hospital, Department of Gastroenterology, Lørenskog, Norway;(11)Vestre Viken Hospital Trust- Bærum Hospital, Department of Internal Medicine, Gjettum, Norway;(12)Østfold Hospital Trust, Department of Gastroenterology, Sarpsborg, Norway;(13)Innlandet Hospital Trust, Department of Internal Medicine, Gjøvik, Norway;(14)Telemark Hospital Trust, Department of Gastroenterology, Skien, Norway;(15)Oslo University Hospital, Department of Paediatrics, Oslo, Norway;(16)Innlandet Hospital Trust, Department of Internal Medicine, Hamar, Norway;
P248: Feasibility, accuracy and reproducibility of the ultrasound measurement of psoas muscle compared to bioelectrical impedance analysis for the evaluation of skeletal muscle mass in patients with IBDECCO'24
Year: 2024
Authors: Fichera, A.(1);Costantino, A.(1)*;Piagnani, A.(2);Baldrighi, S.(3);Roncoroni, L.(1);Vecchi, M.(1);Caprioli, F.(1);Fraquelli, M.(1);
(1)Fondazione IRCCS Ca@E@ Granda Ospedale Maggiore Policlinico, Gastroenterology and Endoscopy, Milan, Italy;(2)Università degli Studi di Milano, Department of Pathophysiology and Transplantation, Milan, Italy;(3)Università degli Studi di Milano, Department of Science and Technologies, Milan, Italy;
P249: Development and validation of a novel model to predict disease behavior progression in Crohn@E@s disease patients with intestinal stenosisECCO'24
Year: 2024
Authors: Wang, Y.(1)*;Chen, H.(1);Mao, R.(1);
(1)The First Affiliated Hospital- Sun Yat-sen University, Gastroenterology and Hepatology, Guangzhou, China;
P250: Geriatric impairments associate with mortality and hospitalisations during follow-up in older IBD outpatients.ECCO'24
Year: 2024
Authors: Fons, A.(1)*;Asscher, V.(1);Stuyt, R.(2);Baven-Pronk, M.(3);van der Marel, S.(4);Jacobs, R.(5);van der Meulen-de Jong, A.(1);Mooijaart, S.(6);Kalisvaart, K.(7);Maljaars, J.(1);
(1)Leiden University Medical Centre, Department of Gastroenterology and Hepatology, Leiden, The Netherlands;(2)Haga Ziekenhuis, Department of Gastroenterology and Hepatology, The Hague, The Netherlands;(3)Groene Hart Ziekenhuis, Department of Gastroenterology and Hepatology, Gouda, The Netherlands;(4)Haaglanden Medical Centre, Department of Gastroenterology and Hepatology, The Hague, The Netherlands;(5)Alrijne Hospital, Department of Gastroenterology and Hepatology, Leiden and Leiderdorp, The Netherlands;(6)Leiden University Medical Centre, Department of Gerontology and Geriatrics, Leiden, The Netherlands;(7)Spaarne Gasthuis, Department of Geriatric Medicine, Haarlem, The Netherlands;
P251: Proactive Therapeutic drug monitoring of Infliximab, but not HLA-DQA1*05, predicts clinical outcome in inflammatory bowel diseaseECCO'24
Year: 2024
Authors: Alonso, I.(1)*;Carrillo Palau, M.(1);Vera, B.(1);Vela, M.(2);Morant, A.(1);Ramos, L.(1);Reygosa, C.(1);Medina Chico, J.S.(1);Barrios, Y.(3);Franco, A.(3);Gutiérrez-Nicolás, F.(4);Jiménez, A.(5);Hernández-Guerra, M.(1);
(1)Inflammatory Bowel Disease Unit. Hospital Universitario De Canarias, Gastroenterology Department, Santa Cruz De Tenerife, Spain;(2)Inflammatory Bowel Disease Unit. Hospital Universitario Nuestra Señora de Candelaria, Gastroenterology Department, Santa Cruz de Tenerife, Spain;(3)Hospital Universitario de Canarias, Immunology Department, Santa Cruz de Tenerife, Spain;(4)Hospital Universitario de Canarias, Pharmacy Department, Santa Cruz de Tenerife, Spain;(5)Hospital Universitario de Canarias, Research, Santa Cruz de Tenerife, Spain;
P252: Male Genitourinary Dysfunction after Minimally Invasive and Open Ileoanal PouchECCO'24
Year: 2024
Authors: Hernandez Dominguez, O.(1)*;Prien, C.(1);Almarzooqi, R.(1);Sanchetti, H.(1);Lavryk, O.(1);Somovilla, J.(1);Kanters, A.(1);Liska, D.(1);Gorgun, E.(1);Hull, T.(1);Steele, S.(1);Holubar, S.(1);
(1)Cleveland Clinic Foundation, Colorectal Surgery, Cleveland, United States;Cleveland Clinic
P253: Knowledge and acceptability of the Lémann Index to measure progressive intestinal damage in Crohn’s disease: results from an international cross-sectional surveyECCO'24
Year: 2024
Authors: Wong, C.(1,2)*;Torres, J.(3,4,5);Burisch, J.(6,7);Ungaro, R.C.(8);Mary, J.Y.(9);Colombel, J.F.(8);Buisson, A.(10,11);Lambert, J.(12);Arebi, N.(1,2);
(1)St Mark@E@s National Bowel Hospital, Department of Inflammatory Bowel Disease, London, United Kingdom;(2)Imperial College London, Department of Metabolism- Digestion and Reproduction, London, United Kingdom;(3)Hospital Beatriz Ângelo, Division of Gastroenterology, Loures, Portugal;(4)Universidade de Lisboa, Faculdade de Medicina, Lisboa, Portugal;(5)Hospital da Luz, Division of Gastroenterology, Lisboa, Portugal;(6)Copenhagen University Hospital – Amager and Hviodvre, Gastrounit- Medical Division, Hvidovre, Denmark;(7)Copenhagen University Hospital – Amager and Hvidovre, Copenhagen Center for Inflammatory Bowel Disease in Children- Adolescents and Adults, Hvidovre, Denmark;(8)Icahn School of Medicine at Mount Sinai, The Henry D. Janowitz Division of Gastroenterology, New York, United States;(9)Université Paris-Cité Hôpital Saint-Louis, CRESS Inserm UMR1153- ECSTRRA team, Paris, France;(10)Université Clermont Auvergne- Inserm, Centre Hospitalier Universitaire Clermont-Ferrand- 3iHP- Service d@E@Hépato-Gastro Entérologie, Clermont-Ferrand, France;(11)Université Clermont Auvergne, 3iHP- Inserm U1071- M2iSH- USC-INRA 2018- F-63000, Clermont-Ferrand, France;(12)INSERM U717 Saint-Louis Hospital, Department of Statistics, Paris, France;
P254: Outcomes of endoscopic and histologic remission in ulcerative colitis under advanced therapyECCO'24
Year: 2024
Authors: Rodrigues, I.(1)*;Bronze, S.(1);Fernandes, S.(1);Saraiva, S.(1);Bernardo, S.(1);Gonçalves, A.R.(1);Moura Santos, P.(1,2);Valente, A.(1);Araújo Correia, L.(1,2);
(1)Centro Hospitalar Universitário Lisboa Norte, Serviço de Gastrenterologia e Hepatologia, Lisbon, Portugal;(2)Faculdade de Medicina de Lisboa, Clínica Universitária de Gastrenterologia, Lisbon, Portugal;